Observational Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Nov 28, 2015; 21(44): 12660-12666
Published online Nov 28, 2015. doi: 10.3748/wjg.v21.i44.12660
Table 1 Baseline characteristics of the patients included in the study n (%)
Population characteristics (n= 106)Value
Male gender47 (44)
Age - mean40 ± 13 yr
Median time between diagnosis and VCE5.5 (IQR 2-10) yr
Montreal classification
Age at diagnosis
A1: Below 177 (7)
A2: 17-4084 (79)
A3: Above 4015 (14)
Behavior
B1: Non-stenosing/non-penetrating86 (81)
B2: Stenosing12 (11)
B3: Penetrating8 (8)
Location
L1: Terminal ileum74 (70)
L2: Colonic10 (9)
L3: Ileocolonic22 (21)
+ L4: Upper disease38 (36)
Treatment before VCE
Anti-TNF21 (20)
Immunosuppressors38 (36)
Aminosalicylates only40 (38)
No treatment7 (6)